Permanent alopecia following chemotherapy and bone marrow transplantation

Australasian Journal of Dermatology

Volumn 41, Issue 2, 2000, Pages 106-108

  Tran, D ^a   Sinclair, R D ^b,e   Schwarer, A P ^c   Chow, C W ^d  

^a Department of Dermatology ^*  (Australia)

^b ALFRED HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e ST VINCENT S HOSPITAL   (Australia)

Author keywords

Busulphan; Cicatricial; Cyclophosphamide; Hair loss; Scarring; Telogen and anagen emuvium

Indexed keywords

ACICLOVIR; BUSULFAN; CEFTAZIDIME; CHLORHEXIDINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUCONAZOLE; FOLINIC ACID; MESNA; METHOTREXATE; MINOXIDIL; NORFLOXACIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VANCOMYCIN;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ALOPECIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; DISEASE COURSE; DRUG INDUCED DISEASE; FEMALE; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE;

EID: 0034069826     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-0960.2000.00405.x     Document Type: Article

References (11)

1. Baxley KO, Erdman LK, Henry EB, Roof BJ. Alopecia: Effect on cancer patients' body image. Cancer A'ursing 1984; 7: 499-503.
2. Sinclair R. Diffuse hair loss: Anagen effluvium. In: Sinclair K, Banfield G, Dawber R (eds). Handbook of Diseases of the Hairand Scalp. Oxford: Black-well Science, 1999; 70-4.
3. Veager AM, Shinn C, Farmer ER, \Vmgard JR, Yeager MJ. Growth retardation and depigmentation of hair after high-dose busulfan and congenic hematopoietic cell transplantation in mice. Bone Marrow Transplant. 1992; 9: 199-204.
4. Baker BW, Wilson CL, Davis AL étal. Bulsulphan/cyclophosphamide conditioning for bone marrow transplantation may lead to failure of hair re-growth. Bone Marrow Transplant. 1991; 7: 43-7.
5. Cotsarelis G, Sun TT, Lavker RM. Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle and skin carcinogenesis. Cell 1990; 61: 1329-37.
6. Oliver RF. Whisker growth after removal of the dermal papilla and lengths of follicle in the hooded rat J. Embrj'ol. Erp. Morphol. 1966; 15:331-47.
7. Ljungman P, Hassan M, Bekassy AN, Ringden O, Oberg G. Busulfan concentration in relation to permanent alopecia in recipients of bone marrow transplants. Bone Marrow Transplant. 1995; 15:869-71.
8. Hassan M, Ljungman P, Bulme P et al. Busulfan bioavailability. Blood 1994; 84: 2144-50.
9. Slattery JT, Clift RA, Buckner CD et al. Marrow transplantation for chronic myeloid leukaemia: The influence of plasma busulfan levels on the outcome of transplantation. Blood 1997; 89: 3055-60.
10. Vowels M, Chan LL, Giri N, Russell S, Lam-Po-Tang R. Factors affecting hair re-growth after bone marrow transplantation. Bone Marrow Transplant. 1993; 12: 347-50.
11. Pinkus RC. Has informed consent finally arrived in Australia? A comment on the law following the decision of the High Court of Australia in Rogers vs. Whitaker. Med. J. Aust. 1993; 159: 25-7.